Who Paid My Doc
Spi-Qap-306
Research payments
$86,495
Through program year 2019, $86,495 in research payments was reported against Spi-Qap-306, across 35 payments, paid by Spectrum Pharmaceuticals Inc..
- Paid by
- Spectrum Pharmaceuticals Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
1 row| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2019 | Research | $86,495 | 35 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Inoel Rivera-Ramirez Orlando, FL Named on 4 payments
- Daniel Burzon Brick, NJ Named on 4 payments
- Benjamin Fand Edison, NJ Named on 3 payments
- Osvaldo Padron Tampa, FL Named on 3 payments
- David Morris Hendersonville, TN Named on 2 payments
- Andrew Trainer Omaha, NE Named on 2 payments
- Ning Wu Lake Barrington, IL Named on 2 payments
- Cynthia Fairfax Meridian, ID Named on 2 payments
- Ralph Henderson Shreveport, LA Named on 2 payments
- Daniel Saltzstein San Antonio, TX Named on 2 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.